02563.HK
Beijing Biostar Pharms Co Ltd
HKSE · Healthcare · Drug Manufacturers - General · CN
HKD 3.40
−4.23%Year over year
Reported trailing growth
- Revenue
- —
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -0.2%
- EBITDA
- +19.6%
- EBIT
- +17.9%
- Net income
- +8.6%
- EPS
- +9.3%
- Free cash flow
- -7.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026